4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-17-032420
Chief Executive Officer acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Suzdak Peter David · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-16 | Grant or award : show line 1 in the form | +10,000 | $1.99 | $19,872 | 16,000 | D |
Loading xslF345X03/form4.xml…